P4‐016: MCLENA‐1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE. (1st July 2019)

Record Type:: Journal Article
Title:: P4‐016: MCLENA‐1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE. (1st July 2019)
Main Title:: P4‐016: MCLENA‐1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE
Authors:: Decourt, Boris
Fulkerson, Nadia
Burns, Alana
Lee, Garam
St Rose, Tessa
Hartley, Katurah
Dardis, Christopher
Wilson, Jeffrey
Sabbagh, Marwan N.
Abstract:
Is Part Of:: Alzheimer's & dementia. Volume 15:Supplement 7S(2019)Part 24
Journal:: Alzheimer's & dementia
Issue:: Volume 15:Supplement 7S(2019)Part 24
Issue Display:: Volume 15, Issue 7, Part 24 (2019)
Year:: 2019
Volume:: 15
Issue:: 7
Part:: 24
Issue Sort Value:: 2019-0015-0007-0024
Page Start:: P1279
Page End:: P1279
Publication Date:: 2019-07-01
Subjects:: Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:: http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.jalz.2019.06.3675 ↗
Languages:: English
ISSNs:: 1552-5260
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13234.xml